Skip to content
Evigrade
ModerateOther antibacterials×Atypical antipsychotics

Updated · Methodology

Mechanism

Quetiapine is extensively metabolised in the liver, mainly by CYP3A4, and its metabolites are excreted in urine and faeces (Seroquel SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.2). Fosfomycin is not metabolised and is excreted by the kidneys (oral fosfomycin SmPC, AEMPS, section 5.2), so the drugs share no metabolic pathway. The link is electrolytes. The quetiapine SmPC calls for caution with drugs known to cause electrolyte imbalance or prolong the QT interval, especially in hypokalaemia or hypomagnesaemia (AEMPS, sections 4.4 and 4.5). According to its SmPC, intravenous fosfomycin can lower serum potassium and, because of its high sodium content, carries a risk of hypernatraemia (Fosfocina SmPC, AEMPS, section 4.4). The oral fosfomycin SmPC describes no such effects.

Symptoms

The documents describe no symptoms specific to the combination. Intravenous fosfomycin can lower potassium, and the sodium load of the solution can cause hypernatraemia and fluid overload, especially in heart failure, cirrhosis, nephrotic syndrome and hypertension (Fosfocina SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.4). Quetiapine causes somnolence and dizziness, and its QT prolongation warning applies especially in hypokalaemia or hypomagnesaemia (Seroquel SmPC, AEMPS, section 4.4).

Management

With intravenous fosfomycin, quetiapine is used with caution, because the quetiapine SmPC calls for caution with drugs known to cause electrolyte imbalance (Seroquel SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.5). Sodium and potassium are checked regularly during intravenous fosfomycin, especially in prolonged treatment, and potassium supplementation should always be considered (Fosfocina SmPC, AEMPS, section 4.4). Before intravenous fosfomycin is started, the risk of sodium and fluid overload is assessed, a low-sodium diet is recommended, and if needed the infusion is lengthened or the single dose reduced and given more often (Fosfocina SmPC, AEMPS, section 4.4). With oral fosfomycin, the documents call for none of these measures. The combination is acceptable without dose changes, and fosfomycin is taken on an empty stomach or 2–3 hours after a meal (oral fosfomycin SmPC, AEMPS, section 4.5).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Quetiapine